HighTower Advisors, LLC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 60 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$3,000
-25.0%
10,2000.0%0.00%
Q4 2019$4,000
+33.3%
10,2000.0%0.00%
Q3 2019$3,0000.0%10,200
-6.4%
0.00%
Q2 2019$3,000
-75.0%
10,900
-15.5%
0.00%
Q1 2019$12,000
-36.8%
12,900
+18.3%
0.00%
Q4 2018$19,000
-69.8%
10,9000.0%0.00%
Q3 2018$63,00010,9000.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,192,080$9,704,0004.11%
Ghost Tree Capital, LLC 219,977$1,790,0001.06%
JBF Capital, Inc. 148,178$1,205,0000.18%
Polar Capital LLP 900,604$7,326,0000.17%
SPHERA FUNDS MANAGEMENT LTD. 80,000$651,0000.15%
HAMILTON LANE ADVISORS LLC 33,141$270,0000.11%
Jasper Ridge Partners, L.P. 63,996$521,0000.03%
Weiss Multi-Strategy Advisers LLC 95,000$773,0000.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 550,000$4,474,0000.01%
AXA S.A. 292,625$2,381,0000.01%
View complete list of CONATUS PHARMACEUTICALS INC shareholders